UC Davis is seeking participants for a study on strontium citrate. This is the press release:
http://www.ucdmc.ucdavis.edu/newsroom/newsdetail.html?key=1985
UC DAVIS STUDY TO PREVENT OSTEOPOROSIS WITH DIETARY SUPPLEMENT BEGINS RECRUITMENT
February 26, 2009
(SACRAMENTO, Calif.) — Osteoporosis affects many women and can cause painful, disabling and even life-threatening fractures. Researchers from the UC Davis Department of Internal Medicine are seeking a simple, inexpensive way to prevent the disease.
Strontium citrate is a widely available, over-the-counter dietary supplement promoted to “improve bone health.” Strontium is a natural element found in bone in all people. Strontium citrate is another form of strontium ranelate, a proven medication prescribed across Europe and Australia to treat and prevent osteoporosis and related fractures. Unlike pharmaceuticals, strontium citrate is not a prescribed medication and is inexpensive.
The UC Davis researchers are trying to demonstrate that a nutraceutical, which women can buy without seeing a doctor or paying a drug company, can be used to improve bone health.
The researchers are seeking post-menopausal women who are at least one year but less than five years past their last menstrual period. Participation in the study will include a screening visit with blood draw at UC Davis Medical Center, followed by a blood draw and free DEXA scan at the Veterans Administration Northern California Health Care Center.
Participants will be randomly assigned to one of two groups. One group will take strontium citrate plus calcium and vitamin D for three months, while the other group will take a placebo plus calcium and vitamin D for three months.
During the three-month period, participants will visit UC Davis Medical Center three times for short questionnaires and blood draws. DEXA scans and test results can be provided to participants.
For more information or to schedule a screening visit, contact Stephanie Burns, study coordinator, at (530) 754-7576 or (916) 734-5562 or scope@phs.ucdavis.edu.
UC Davis Health System is an integrated, academic health system encompassing UC Davis School of Medicine, the 613-bed acute-care hospital and clinical services of UC Davis Medical Center, the 800-member physician group known as UC Davis Medical Group, and the proposed Betty Irene Moore School of Nursing.
Already a member? Sign in
Welcome to Inspire!
What - Inspire is a place where you can connect with people who share your health concerns and find information and advice in groups sponsored by organizations you know and trust.
Why - As a member you can use Inspire to let friends and family know how you're doing, contact others who share your health concerns, receive personalized updates and information about participating in surveys and clinical trials, and more.
How - Joining Inspire is completely free and usually takes less than a minute. Join now!
Strontium Citrate Study at UC Davis
- By PikaB
- Posted February 27, 2009 at 7:24 pm · 3 replies
- In Clinical trials
- Shared with the public
Explore topics in this discussion:
3 replies
- Oldest first
- Newest first
- By drizzit
- Posted February 28, 2009 at 12:26 am
- Report post
Is three months long enough to show a result? interesting to see the results.
- By April995
- Posted March 1, 2009 at 5:22 am
- Report post
Thanks Pika,
I just emailed off the web page to my Dr. friend.
When he came for a visit a month ago, he read the brochure I gave him on Strontium, and said, let me knows how it goes!
Just like a Dr. lol..
I don't think 3 months is long enough either for this test, but at least Strontium is getting noticed from the Drs. now.
My Endo Dr. never heard of it, and I live in Ca. about a 2 1/2 hour drive from UC Davis.
April
- By zeta
- Posted March 12, 2009 at 8:04 pm
- Report post
PikaB, thanks for bringing this important information to the atttention of this group. I contacted one of the UCD researchers, and learned that this is a pilot study, and biochemical markers will be used to evaluate the efficacy of strontium citrate, NOT DXA'S. This will increase the likelihood of demonstrating that the non-prescription supplement strontium citrate, which has few to virtually no negative side effects, will improve bone health.
If the pilot study does produce positive rusults, UCD will then be in a better position to seek funding for a long-term study. I wish them luck!! I imagine it is difficult to obtain funding for a supplement that can't be patented and sold for a profit.
More power to them. I'm very excited about their work. Their heads and hearts, in my opinion are in the right place. Let's all tip our hats, and hope for the best.
zeta
Add to the discussion